Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director Appointments and Resignation

27 Feb 2020 07:00

RNS Number : 2632E
Dialight PLC
27 February 2020
 

 

27 February 2020

 

DIALIGHT PLC

 

Director Appointments and Resignation

 

Appointments

The Board of Dialight plc (the "Company") is pleased to announce the appointments of Karen Oliver and Gotthard Haug as non-executive directors of the Company, both with effect from 1 April 2020.

Karen currently combines independent consulting with her role as a non-executive director of The ARVOS Group, which is a world-leading manufacturer of industrial equipment and headquartered in Germany. She was formerly Managing Director of Johnson Matthey plc's Chemicals business; Head of Strategy & Business Planning at Foster Wheeler AG; and Head of Global Business Development, Tonnage at the Linde Group. She was also a non-executive director of African Oxygen Ltd, which is listed on the Johannesburg Stock Exchange and the Namibian Stock Exchange. Karen holds a BSc in Chemical Engineering from the University of Cape Town.

Gotthard is the Executive Chairman of Ivy Technology, a leading global electronics repair and service provider to many of the world's largest tech, med-tech and telecommunications companies. He is also a Partner of 'taskforce - Management on Demand GmbH', an Advisory Board Member of iGlobe Partners and an Independent Consultant and Interim Executive of Minerva Management Partners. Among his many senior roles in the manufacturing industry, Gotthard was previously CEO and CFO of Teleplan International and a non-executive director of Psion. He was also the Chairman of Ultratec Ltd. Gotthard holds a MBA and a BA from Ludwig-Maximilians-Universität München.

Resignation

With effect from 31 March 2020, Steve Good will step down as a director of the Company so as to allow him to focus on his other directorships.

Chairman's comments

Commenting on the appointments and Steve's departure, David Blood, Chairman of the Company said:

"I am delighted to welcome Karen and Gotthard to Dialight's Board of Directors. Both of them have extensive manufacturing sector experience, and will bring skills and insights that will complement our existing team."

"It has been a privilege to work with Steve, who has provided the Company with invaluable service since he joined us. We are sorry to see him go and wish him all the best with his other board commitments."

There are no further matters to be disclosed pursuant to Rule 9.6.13 of the Listing Rules.

 

For further information contact:

 

Dialight plc

Richard Allan

General Counsel and Company Secretary

Tel: +44 (0) 203 058 3546

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAXAKASEEEFA
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.